These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 29303974)

  • 21. Microbes and microbial effector molecules in treatment of inflammatory disorders.
    Kelly D; Delday MI; Mulder I
    Immunol Rev; 2012 Jan; 245(1):27-44. PubMed ID: 22168412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of the mechanisms of probiotic actions in the prevention of colorectal cancer.
    Dos Reis SA; da Conceição LL; Siqueira NP; Rosa DD; da Silva LL; Peluzio MD
    Nutr Res; 2017 Jan; 37():1-19. PubMed ID: 28215310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.
    Vitetta L; Vitetta G; Hall S
    Front Immunol; 2018; 9():2240. PubMed ID: 30356736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics and prebiotics in infectious gastroenteritis.
    Vandenplas Y
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):49-53. PubMed ID: 27048896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics that modify disease risk.
    Salminen SJ; Gueimonde M; Isolauri E
    J Nutr; 2005 May; 135(5):1294-8. PubMed ID: 15867327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
    Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
    J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Effects and mechanisms of probiotics, prebiotics, synbiotics and postbiotics on intestinal health and disease.
    Wang G; Ding T; Ai L
    Front Cell Infect Microbiol; 2024; 14():1430312. PubMed ID: 38979509
    [No Abstract]   [Full Text] [Related]  

  • 29. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical and clinical relevance of probiotics and synbiotics in colorectal carcinogenesis: a systematic review.
    Cruz BCS; Sarandy MM; Messias AC; Gonçalves RV; Ferreira CLLF; Peluzio MCG
    Nutr Rev; 2020 Aug; 78(8):667-687. PubMed ID: 31917829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations of Bacteroides spp. towards next-generation probiotics.
    Tan H; Zhai Q; Chen W
    Food Res Int; 2019 Feb; 116():637-644. PubMed ID: 30716990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of probiotics and synbiotics in children under 18 years of age.
    van den Nieuwboer M; Brummer RJ; Guarner F; Morelli L; Cabana M; Claassen E
    Benef Microbes; 2015; 6(5):615-30. PubMed ID: 25809217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age.
    Cucchiara S; Falconieri P; Di Nardo G; Parcelii MA; Dito L; Grandinetti A
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S44-7. PubMed ID: 12408439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antivirulence Properties of Probiotics in Combating Microbial Pathogenesis.
    Surendran Nair M; Amalaradjou MA; Venkitanarayanan K
    Adv Appl Microbiol; 2017; 98():1-29. PubMed ID: 28189153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial Effects of Probiotic Consumption on the Immune System.
    Maldonado Galdeano C; Cazorla SI; Lemme Dumit JM; Vélez E; Perdigón G
    Ann Nutr Metab; 2019; 74(2):115-124. PubMed ID: 30673668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerogenic probiotics: potential immunoregulators in Systemic Lupus Erythematosus.
    Esmaeili SA; Mahmoudi M; Momtazi AA; Sahebkar A; Doulabi H; Rastin M
    J Cell Physiol; 2017 Aug; 232(8):1994-2007. PubMed ID: 27996081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The vermiform appendix: an immunological organ sustaining a microbiome inoculum.
    Vitetta L; Chen J; Clarke S
    Clin Sci (Lond); 2019 Jan; 133(1):1-8. PubMed ID: 30606811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of intestinal microbiota and the immune system.
    Purchiaroni F; Tortora A; Gabrielli M; Bertucci F; Gigante G; Ianiro G; Ojetti V; Scarpellini E; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):323-33. PubMed ID: 23426535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dysbacteriosis and preparations with probiotic function].
    Bondarenko VM; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (1):84-92. PubMed ID: 15024992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
    Blum S; Schiffrin EJ
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):53-60. PubMed ID: 14503689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.